From: Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology
Study | Compounds of XBJa | Targets of XBJb | Potential targets of COVID-19 | Results | Software and tools | Combine with other targetsc |
---|---|---|---|---|---|---|
Zhang et al | Based on TCMSP database (2014 version) with oral bioavailability (OB) ≥ 30% and drug-likeness (DL) ≥ 0.18. | TCMSP database. | Based on the GeneCards database. | 8 key compounds: Luteolin, Quercetin, Baicalein, Kaempferol, Tanshinone II A, Myricanone, Dan-shexinkum d, Ellagic acid. 15 key targets: DPP4, AR, ESR1, CALM1, AKT1, CASP3, NOS3, VEGF-A, TP53, BCL2, TNF, JUN, CDKN1A, FOS and BAX. | Topology analysis: Network Analyzer. Network construction: Cytoscape. Enrichment analysis: Metascape, DAVID database. Molecular docking: Ligand Docking module of Schrödinger. | NO. |
The current research | Selected active ingredients that had been detected by liquid chromatography-mass spectrometry (LC-MS). | Swiss database. | On the basis of Zhang’s research, we added two ways to search for disease targets, including literature search and ACE co-expressed genes. | 18 key compounds were showed in Fig. 8. 10 key targets: GAPDH, ALB, TNF, EGFR, MAPK1, CASP3, STAT3, MAPK8, PTGS2, JUN, IL-2, ESR1, and MAPK14. | Topology analysis: STRING and cytoHubba. Network construction: Cytoscape. Enrichment analysis: R software 3.5.2, org.Hs.eg.db package, clusterProfiler package, and ClueGO. Molecular docking: Auto Dock vina, AutoDockTools, Protein Data Bank, and PyMOL. | YES. Combine with other targets like putative COVID-19-interacting human proteins. |